Cancer stage describes the extent of disease in the body. For pleural mesothelioma, doctors commonly use the TNM system and assign an overall stage from I through IV. Stage is important, but it is only one factor in selecting treatment and discussing prognosis.
The TNM framework
- T—Tumor: the location and extent of the primary tumor.
- N—Nodes: whether cancer is present in regional lymph nodes.
- M—Metastasis: whether cancer has spread to distant sites.
The combination determines a stage group. Staging descriptions are technical and may change as medical organizations update classification systems. Ask the care team to explain the stage recorded in the medical file and which edition of the staging system was used.
Stage I
Stage I pleural mesothelioma is limited to the lining on one side of the chest, although the exact structures involved distinguish stage IA from IB. Nearby tissue may be involved in stage IB, but regional lymph-node or distant spread is not present under the current framework.
Some patients with localized disease may be evaluated for surgery as part of a multimodal plan. Health, cell type, tumor distribution and center experience all matter.
Stage II
Stage II generally describes disease involving the pleura on one side with specified local extension and/or regional lymph nodes on the same side. Treatment is individualized and may include systemic therapy, surgery in selected circumstances, radiation, symptom management or clinical trials.
Stage III
Stage III disease is divided into IIIA and IIIB. It may involve more extensive local structures and/or particular regional lymph nodes. Whether surgery is feasible depends on the exact anatomy, health and specialist assessment rather than stage number alone.
Stage IV
Stage IV means mesothelioma has spread to distant or specified opposite-side locations. It is also called metastatic mesothelioma. Cancer found in another organ remains mesothelioma; it does not become a new type of cancer based on the organ involved.
Treatment may focus on controlling cancer, relieving symptoms, maintaining function and quality of life, and considering clinical trials.
How staging is performed
Tests may include CT, PET, MRI and procedures to sample tissue or lymph nodes. The care team selects tests based on cancer location, planned treatment and individual health considerations.
Staging based on imaging before treatment is called clinical staging. Information obtained during surgery can contribute to pathologic staging. The two may differ because surgery can reveal findings not visible on scans.
Peritoneal and rare forms
The pleural TNM stage groups should not be applied casually to peritoneal, pericardial or testicular mesothelioma. Specialists may use disease distribution, surgical scoring systems or other clinical descriptions.
Questions for the care team
- What is the full TNM classification and overall stage?
- Which tests established the stage?
- Is the stage clinical or pathologic?
- Could additional testing change the treatment plan?
- Is surgery being considered, and why or why not?
- Are clinical trials available for this stage and treatment history?
Sources
- National Cancer Institute. Stages of Mesothelioma Updated May 16, 2025.
- National Cancer Institute. Malignant Mesothelioma Treatment—Health Professional Version.
Reviewed: [Add only after completed medical review]